Clinical Trial

A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This single-part, healthy volunteer study will try to identify how the test medicine is taken up, broken down and removed from the body. To help investigate this, the test medicine is radiolabelled, which means that the test medicine has a radioactive component (carbon-14) which helps us to track where the test medicine is in the body. The safety and tolerability of the test medicine will also be studied.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-06-09
notable Primary completion moved earlier: 2026-03 -> 2026-01-28 2026-06-09
minor Completion moved earlier: 2026-03 -> 2026-01-28 2026-06-09
Trial Details
NCT Number NCT07320521
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Breast Cancer
Enrollment 6 participants
Start Date 2026-01-09
Primary Completion 2026-01-28 (estimated)
Study Completion 2026-01-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-08